共 7 条
[1]
Plasma levels of C-reactive protein after coronary stent implantation. Wolf MG,Zasmeta G,Hornykewycz S,et al. European Heart Journal . 2000
[2]
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Jianhui Zhu,Quyyumi AA,Norman JE,et al. The American Journal of Cardiology . 2000
[3]
C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Tataru MC,Heinrich J,Junker R,et al. European Heart Journal . 2000
[4]
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. Ridker PM,Rifai N,Clearfield M,et al. The New England Journal of Medicine . 2001
[5]
Actue-phase proteins and other systemic responses to inflammation. Gabay C,Kushner I. The New England Journal of Medicine . 1999
[6]
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. Lenine B,Kalman J,Mayer L,et al. The New England Journal of Medicine . 1990
[7]
HMG- COA reductase inhibition by atorvastatin reduces neointial inflammation in a rabbit model of atherosclerosis. Bustos C,Hernandez-Presa MA,Ortego M,et al. Journal of the American College of Cardiology . 1998